SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking

[1]  J. Matson,et al.  Autism severity as a predictor of inattention and impulsivity in toddlers , 2015, Developmental Neurorehabilitation.

[2]  R. Landa,et al.  Association between severity of behavioral phenotype and comorbid attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders , 2014, Autism : the international journal of research and practice.

[3]  Evan J. Kyzar,et al.  Decoding the contribution of dopaminergic genes and pathways to autism spectrum disorder (ASD) , 2014, Neurochemistry International.

[4]  Eric Gouaux,et al.  X-ray structure of dopamine transporter elucidates antidepressant mechanism , 2013, Nature.

[5]  J. Matson,et al.  The relationship between autism spectrum disorders and attention-deficit/hyperactivity disorder: an overview. , 2013, Research in developmental disabilities.

[6]  J. Sutcliffe,et al.  De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder , 2013, Molecular Psychiatry.

[7]  Charles J. Lynch,et al.  Underconnectivity between voice-selective cortex and reward circuitry in children with autism , 2013, Proceedings of the National Academy of Sciences.

[8]  M. Leitges,et al.  Protein kinase Cβ is a modulator of the dopamine D2 autoreceptor‐activated trafficking of the dopamine transporter , 2013, Journal of neurochemistry.

[9]  B. Franke,et al.  The dopamine transporter haplotype and reward-related striatal responses in adult ADHD , 2013, European Neuropsychopharmacology.

[10]  D. Murphy,et al.  Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care , 2013, Psychopharmacology.

[11]  Kathryn Roeder,et al.  Analysis of Rare, Exonic Variation amongst Subjects with Autism Spectrum Disorders and Population Controls , 2013, PLoS genetics.

[12]  Kathryn Roeder,et al.  Rare Complete Knockouts in Humans: Population Distribution and Significant Role in Autism Spectrum Disorders , 2013, Neuron.

[13]  W. Roberts,et al.  Clinical Practice Pathways for Evaluation and Medication Choice for Attention-Deficit/Hyperactivity Disorder Symptoms in Autism Spectrum Disorders , 2012, Pediatrics.

[14]  Evan M Gordon,et al.  Effect of dopamine transporter genotype on intrinsic functional connectivity depends on cognitive state. , 2012, Cerebral cortex.

[15]  T. Takumi,et al.  Altered Serotonin, Dopamine and Norepinepherine Levels in 15q Duplication and Angelman Syndrome Mouse Models , 2012, PloS one.

[16]  K. Roelofs,et al.  Dopamine transporter polymorphisms affect social approach–avoidance tendencies , 2012, Genes, brain, and behavior.

[17]  Bernie Devlin,et al.  Genetic architecture in autism spectrum disorder. , 2012, Current opinion in genetics & development.

[18]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[19]  Michael Gill,et al.  Attention Deficit/Hyperactivity Disorder-Derived Coding Variation in the Dopamine Transporter Disrupts Microdomain Targeting and Trafficking Regulation , 2012, The Journal of Neuroscience.

[20]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[21]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[22]  S. Roux,et al.  Psychostimulants for ADHD-like symptoms in individuals with autism spectrum disorders , 2012, Expert review of neurotherapeutics.

[23]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[24]  W. A. Owens,et al.  Rescue of Dopamine Transporter Function in Hypoinsulinemic Rats by a D2 Receptor–ERK-Dependent Mechanism , 2012, The Journal of Neuroscience.

[25]  G. Dichter,et al.  Reward Circuitry Function in Autism During Face Anticipation and Outcomes , 2011, Journal of Autism and Developmental Disorders.

[26]  Scott J. Russo,et al.  Impaired Striatal Akt Signaling Disrupts Dopamine Homeostasis and Increases Feeding , 2011, PloS one.

[27]  U. Gether,et al.  SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation , 2011, Pharmacological Reviews.

[28]  W. Staal,et al.  Brief Report: The Dopamine-3-Receptor Gene (DRD3) is Associated with Specific Repetitive Behavior in Autism Spectrum Disorder (ASD) , 2011, Journal of Autism and Developmental Disorders.

[29]  Boris Yamrom,et al.  Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders , 2011, Neuron.

[30]  Kathryn Roeder,et al.  Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.

[31]  H. Kokki,et al.  Effects of Fluoxetine Treatment on Striatal Dopamine Transporter Binding and Cerebrospinal Fluid Insulin-Like Growth Factor-1 in Children with Autism , 2011, Neuropediatrics.

[32]  J. Rothman,et al.  Erratum: A lateralized brain network for visuospatial attention , 2011, Nature Neuroscience.

[33]  K. Schroder,et al.  Macrophage Activation and Differentiation Signals Regulate Schlafen-4 Gene Expression: Evidence for Schlafen-4 as a Modulator of Myelopoiesis , 2011, PloS one.

[34]  E. Hatchwell,et al.  Association of DRD4 polymorphism with severity of oppositional defiant disorder, separation anxiety disorder and repetitive behaviors in children with autism spectrum disorder , 2010, The European journal of neuroscience.

[35]  J. Javitch,et al.  Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expression. , 2010, ACS chemical neuroscience.

[36]  Gary D Bader,et al.  Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.

[37]  R. Blakely,et al.  Dysregulation of Dopamine Transporters via Dopamine D2 Autoreceptors Triggers Anomalous Dopamine Efflux Associated with Attention-Deficit Hyperactivity Disorder , 2010, The Journal of Neuroscience.

[38]  R. Poldrack,et al.  Reward processing in autism , 2010, Autism research : official journal of the International Society for Autism Research.

[39]  A. Newton,et al.  Protein kinase C: poised to signal. , 2010, American journal of physiology. Endocrinology and metabolism.

[40]  H. Faras,et al.  Autism spectrum disorders , 2010, Annals of Saudi medicine.

[41]  Yasuomi Ouchi,et al.  Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. , 2010, Archives of general psychiatry.

[42]  K. Mirnics,et al.  Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression , 2009, Molecular Psychiatry.

[43]  Sarah Curran,et al.  A Common Variant in DRD3 Receptor Is Associated with Autism Spectrum Disorder , 2009, Biological Psychiatry.

[44]  K. Gadow,et al.  Comparative Study of Children With ADHD Only, Autism Spectrum Disorder + ADHD, and Chronic Multiple Tic Disorder + ADHD , 2009, Journal of attention disorders.

[45]  S. Robertson,et al.  A Closer Look at Amphetamine-Induced Reverse Transport and Trafficking of the Dopamine and Norepinephrine Transporters , 2009, Molecular Neurobiology.

[46]  B. Kolachana,et al.  Variation in dopamine genes influences responsivity of the human reward system , 2009, Proceedings of the National Academy of Sciences.

[47]  J. Gilbert,et al.  Examination of association to autism of common genetic variationin genes related to dopamine , 2008, Autism research : official journal of the International Society for Autism Research.

[48]  E. Hatchwell,et al.  Association of ADHD, tics, and anxiety with dopamine transporter (DAT1) genotype in autism spectrum disorder. , 2008, Journal of child psychology and psychiatry, and allied disciplines.

[49]  Edwin H. Cook,et al.  Copy-number variations associated with neuropsychiatric conditions , 2008, Nature.

[50]  S. Steinberg.  Structural basis of protein kinase C isoform function. , 2008, Physiological reviews.

[51]  J. Javitch,et al.  PI3K signaling supports amphetamine-induced dopamine efflux. , 2008, Biochemical and biophysical research communications.

[52]  R. Blakely,et al.  Anomalous Dopamine Release Associated with a Human Dopamine Transporter Coding Variant , 2008, The Journal of Neuroscience.

[53]  C. Schwartz,et al.  A DRD1 haplotype is associated with risk for autism spectrum disorders in male‐only affected sib‐pair families , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[54]  R. Palmiter.  Dopamine Signaling in the Dorsal Striatum Is Essential for Motivated Behaviors , 2008, Annals of the New York Academy of Sciences.

[55]  Ekaterina Boudanova,et al.  Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent , 2008, Neuropharmacology.

[56]  Joshua M. Korn,et al.  Association between microdeletion and microduplication at 16p11.2 and autism. , 2008, The New England journal of medicine.

[57]  D. Pinto,et al.  Structural variation of chromosomes in autism spectrum disorder. , 2008, American journal of human genetics.

[58]  J. Javitch,et al.  Currents in Response to Rapid Concentration Jumps of Amphetamine Uncover Novel Aspects of Human Dopamine Transporter Function , 2008, The Journal of Neuroscience.

[59]  J. Gore,et al.  Hypoinsulinemia Regulates Amphetamine-Induced Reverse Transport of Dopamine , 2007, PLoS biology.

[60]  A. Björklund,et al.  Fifty years of dopamine research , 2007, Trends in Neurosciences.

[61]  Kenny Q. Ye,et al.  Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.

[62]  J. Javitch,et al.  Dopamine Transporter Activity Mediates Amphetamine-Induced Inhibition of Akt through a Ca2+/Calmodulin-Dependent Kinase II-Dependent Mechanism , 2007, Molecular Pharmacology.

[63]  J. Javitch,et al.  Regulation of Dopamine Transporter Trafficking by Intracellular Amphetamine , 2006, Molecular Pharmacology.

[64]  Randy D. Blakely,et al.  Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder , 2005, Neuropharmacology.

[65]  R. Blakely,et al.  Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala , 2005, Neuropharmacology.

[66]  B. Guptaroy,et al.  Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation , 2005, Neuropharmacology.

[67]  A. Philippi,et al.  Haplotypes in the gene encoding protein kinase c-beta (PRKCB1) on chromosome 16 are associated with autism , 2005, Molecular Psychiatry.

[68]  M. Loder,et al.  Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization , 2005, Nature Neuroscience.

[69]  J. Javitch,et al.  Akt Is Essential for Insulin Modulation of Amphetamine-Induced Human Dopamine Transporter Cell-Surface Redistribution , 2005, Molecular Pharmacology.

[70]  D. Sulzer,et al.  Mechanisms of neurotransmitter release by amphetamines: A review , 2005, Progress in Neurobiology.

[71]  B. Guptaroy,et al.  Regulation of Amphetamine-stimulated Dopamine Efflux by Protein Kinase C β* , 2005, Journal of Biological Chemistry.

[72]  Jonathan A Javitch,et al.  Amphetamine induces dopamine efflux through a dopamine transporter channel. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[73]  A. Sorkin,et al.  Constitutive and Protein Kinase C‐Induced Internalization of the Dopamine Transporter is Mediated by a Clathrin‐Dependent Mechanism , 2005, Traffic.

[74]  T. Uchiyama,et al.  The clinical necessity for assessing Attention Deficit/Hyperactivity Disorder (AD/HD) symptoms in children with high-functioning Pervasive Developmental Disorder (PDD) , 2004, European Child & Adolescent Psychiatry.

[75]  S. Goldstein,et al.  The Comorbidity of Pervasive Developmental Disorder and Attention Deficit Hyperactivity Disorder: Results of a Retrospective Chart Review , 2004, Journal of autism and developmental disorders.

[76]  T. Autti,et al.  Increased presynaptic dopamine function in Asperger syndrome , 2004, Neuroreport.

[77]  J. Javitch,et al.  Amphetamine Regulation of Dopamine Transport , 2004, Journal of Biological Chemistry.

[78]  J. Javitch,et al.  N-Terminal Phosphorylation of the Dopamine Transporter Is Required for Amphetamine-Induced Efflux , 2004, PLoS biology.

[79]  M. Loder,et al.  The Dopamine Transporter Constitutively Internalizes and Recycles in a Protein Kinase C-regulated Manner in Stably Transfected PC12 Cell Lines* , 2003, Journal of Biological Chemistry.

[80]  Hideyuki Takahashi,et al.  Phenylarsine oxide and H2O2 plus vanadate induce reverse translocation of phorbol-ester-activated PKCbetaII. , 2003, Cell structure and function.

[81]  R. Blakely,et al.  A Regulated Interaction of Syntaxin 1A with the Antidepressant-Sensitive Norepinephrine Transporter Establishes Catecholamine Clearance Capacity , 2003, The Journal of Neuroscience.

[82]  N. Zahniser,et al.  Brief, repeated exposure to substrates down‐regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo , 2002, Journal of neurochemistry.

[83]  N. Volkow,et al.  Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence , 2001, The Journal of Neuroscience.

[84]  D. Geschwind,et al.  A genomewide screen for autism susceptibility loci. , 2001, American journal of human genetics.

[85]  B. Leventhal,et al.  The Autism Diagnostic Observation Schedule—Generic: A Standard Measure of Social and Communication Deficits Associated with the Spectrum of Autism , 2000, Journal of autism and developmental disorders.

[86]  J. Javitch,et al.  Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[87]  S. Cichon,et al.  Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1) , 2000, Molecular Psychiatry.

[88]  Wolfgang Ziegler,et al.  Multiple pathways control protein kinase C phosphorylation , 2000, The EMBO journal.

[89]  M. Kavanaugh,et al.  Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. , 1997, The Journal of pharmacology and experimental therapeutics.

[90]  S. J. Gatley,et al.  Relationship between subjective effects of cocaine and dopamine transporter occupancy , 1997, Nature.

[91]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[92]  D. Mochly‐Rosen,et al.  C2 Region-derived Peptides Inhibit Translocation and Function of β Protein Kinase C in Vivo(*) , 1995, The Journal of Biological Chemistry.

[93]  A. Couteur,et al.  Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders , 1994, Journal of autism and developmental disorders.

[94]  H. Lester,et al.  Steady states, charge movements, and rates for a cloned GABA transporter expressed in Xenopus oocytes , 1993, Neuron.

[95]  M. Caron,et al.  Molecular characterization of the dopamine transporter. , 1993, Trends in pharmacological sciences.

[96]  E. D. De Souza,et al.  Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport. , 1991, The Journal of pharmacology and experimental therapeutics.